Clinical Trial Update: Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating pembrolizumab in combination with a single-agent chemotherapy as first-line treatment for locally advanced or metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: University of Rochester | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: RECRUITING